Study Summary
This trial will aim to increase understanding of how smoked cannabis affects cognition and driving ability, as well as how long these effects last. It will also look at how prior experience with cannabis use affects these abilities.
- Cannabis Impairment
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
3 Primary · 2 Secondary · Reporting Duration: Post placebo at 30 minutes and post active dose administration at: 30 minutes, 60 minutes , 90 minutes, 120 minutes, 150 minutes, 180 minutes.
Trial Safety
Phase-Based Safety
Side Effects for
Trial Design
2 Treatment Groups
Placebo Marijuana
1 of 2
Medium THC Marijuana
1 of 2
Experimental Treatment
32 Total Participants · 2 Treatment Groups
Primary Treatment: Medium THC · Has Placebo Group · Phase 1
Trial Logistics
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 55 · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Connecticut | 33.3% |
| Texas | 33.3% |
| New Jersey | 33.3% |
How old are they?
| 18 - 65 | 100.0% |
What site did they apply to?
| Olin Neuropsychiatry Research Center | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
How many prior treatments have patients received?
| 0 | 100.0% |
How responsive is this trial?
Most responsive sites:
- Olin Neuropsychiatry Research Center: < 48 hours
Average response time
- < 2 Days
Typically responds via
| Phone Call | 50.0% |
| 50.0% | |
Frequently Asked Questions
Are youthful participants being accepted for the experiment?
"Participants must fall in the 18 to 55 year old demographic to be considered for this study. For those who are younger or older than that age bracket, there are various other trials available with different eligibility requirements." - Anonymous Online Contributor
To what degree could consuming Medium THC be detrimental to a patient's health?
"The minimal evidence regarding Medium THC's safety and efficacy leads to a score of 1." - Anonymous Online Contributor
What is the magnitude of people involved in this experiment?
"Affirmative. Clinicaltrials.gov data confirms that this medical experiment, which was originally posted on August 25th 2022, is currently recruiting participants. 32 individuals must be recruited from a single site for the trial's completion." - Anonymous Online Contributor
Is this experiment pioneering a new approach?
"Presently, 32 cities across 5 countries are hosting 31 distinct clinical trials for a pharmaceutical called 'Medium THC'. Jazz Pharmaceuticals initiated the first study of its kind in 2015 and it was composed of 200 patients. Since then, 60 such experiments have been concluded." - Anonymous Online Contributor
Are there any reports of previous research on the effects of Medium THC?
"Currently, 31 clinical trials involving Medium THC are actively running with 3 of them in their finale stage. Hartford Connecticut is the hub for many of these studies; however, there are 46 other locations that administer tests and collect data on this medication." - Anonymous Online Contributor
Is enrollment still available for this experiment?
"Indeed, the information hosted on clinicaltrials.gov denotes that this investigation is presently recruiting participants. This venture was initially posted on August 25th 2022 and has since been amended; 32 people are sought from a single location." - Anonymous Online Contributor
To what extent should certain individuals be targeted to enroll in this experiment?
"For acceptance into this trial, applicants should have a history of marijuana abuse and be between the ages of 18-55. This research project has 32 available slots in total." - Anonymous Online Contributor